1. Home
  2. POST vs GKOS Comparison

POST vs GKOS Comparison

Compare POST & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Post Holdings Inc.

POST

Post Holdings Inc.

HOLD

Current Price

$98.43

Market Cap

5.8B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$114.07

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POST
GKOS
Founded
1895
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
POST
GKOS
Price
$98.43
$114.07
Analyst Decision
Buy
Strong Buy
Analyst Count
6
14
Target Price
$125.33
$127.71
AVG Volume (30 Days)
763.6K
647.5K
Earning Date
02-05-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
5.51
N/A
Revenue
$8,158,100,000.00
$469,820,000.00
Revenue This Year
$5.15
$31.15
Revenue Next Year
$0.37
$24.15
P/E Ratio
$17.51
N/A
Revenue Growth
2.97
30.38
52 Week Low
$95.07
$73.16
52 Week High
$119.85
$163.71

Technical Indicators

Market Signals
Indicator
POST
GKOS
Relative Strength Index (RSI) 45.40 62.08
Support Level $96.25 $109.07
Resistance Level $100.36 $117.94
Average True Range (ATR) 2.08 2.73
MACD -0.11 -0.95
Stochastic Oscillator 31.74 57.25

Price Performance

Historical Comparison
POST
GKOS

About POST Post Holdings Inc.

Post Holdings Inc is an consumer packaged goods holding company. It operates in Post Consumer Brands which Includes branded and private label ready-to-eat cereals, Weetabix Includes the businesses of Weetabix Limited, which Post acquired in July 2017 and which produces and distributes branded and private label RTE cereal, hot cereals and other cereal-based food products, Foodservice which Includes egg and potato products in the foodservice and food ingredient channels from the businesses of MFI Holding Corporation, lastly Refrigerated Retail segment Provides refrigerated retail products, inclusive of side dishes, eggs and egg products, sausage, cheese and other dairy and refrigerated products.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: